Photocure ASA - Repurchase program of own shares
PHOTOCURE - REPURCHASE PROGRAM OF OWN SHARES
Oslo, Norway, 5 December 2011:
According to the resolution made by the Annual General Meeting on 27 April
2011, the Board of Directors of Photocure ASA was given Power of Attorney to
acquire own shares in connection with employee share purchase program. In
accordance with the resolution, the Board of Directors of Photocure ASA has
decided to acquire up to 250 000 shares.
The repurchase program will be initiated today, and will be carried out in
accordance with the resolution from the Annual General Meeting. For more details
on the program, please download the minutes from www.photocure.com (under
Investors/Share information).
For further information contact:
Photocure
President & CEO Kjetil Hestdal
Tel: + 47 913 19 535, Email: kh@photocure.no
M:Communications
Mary Clark, Amber Bielecka, Hollie Vile
Tel: +44 207920 2361, Email:photocure@mcomgroup.com
About Photocure ASA
Photocure ASA is a worldwide leader in photodynamic technology. Listed on the
Oslo Stock Exchange (OSE: PHO), Photocure is focused on photodynamic
technologies in dermatology and cancer. The company strives to solve unmet needs
by developing new and innovative solutions based on its patented Photocure
Technology(TM). Photocure markets and sells its own products in selected markets
and has developed strong partnerships with leading pharmaceutical companies on a
regional and global basis. Photocure's bladder cancer diagnostic product, Hexvix
is approved in Europe and the US. In addition, the company markets Allumera®, a
photodynamic cosmetic in the US. Setting new standards for diagnosis and
treatment of several different conditions, Photocure Technology(TM) is
continuously being tested for new products and applications in cancer and
dermatology. Allumera®, Photocure® and Hexvix® are registered trademarks of
Photocure ASA. For more information about Photocure, visitwww.photocure.com.
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1568838]